Plasmin inhibitor reduces T-cell lymphoid tumor growth by suppressing matrix metalloproteinase-9-dependent CD11b(+)/F4/80(+) myeloid cell recruitment.
Ishihara M, Nishida C, Tashiro Y, Gritli I, Rosenkvist J, Koizumi M, Okaji Y, Yamamoto R, Yagita H, Okumura K, Nishikori M, Wanaka K, Tsuda Y, Okada Y, Nakauchi H, Heissig B, Hattori K.
Ishihara M, et al. Among authors: hattori k.
Leukemia. 2012 Feb;26(2):332-9. doi: 10.1038/leu.2011.203. Epub 2011 Sep 20.
Leukemia. 2012.
PMID: 21931322